Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1154 | 1044 | 1185 | 1152 | 1358 | 1832 |
Fund Return | 15.42% | 4.42% | 18.51% | 4.84% | 6.32% | 6.24% |
Place in category | 644 | 707 | 617 | 532 | 389 | 142 |
% in Category | 66 | 73 | 62 | 60 | 46 | 28 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife S2 Ideal US Div incm 100PL | 637.69M | 21.17 | 2.91 | 10.88 | ||
Manulife S2 Idl US Div incm Fd 75PL | 637.69M | 21.69 | 3.34 | 11.23 | ||
Manulife S2 Ideal US Div incm Fd 75 | 637.69M | 21.10 | 2.80 | 10.64 | ||
Manulife S2 Idl US Div incm Fd 100 | 637.69M | 20.51 | 2.30 | 10.23 | ||
Manulife Ideal US Div incm Fd BEL | 637.69M | 21.78 | 3.40 | 11.16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC Sel Gr Port Sr F CAD | 18.22B | 18.79 | 6.23 | 7.95 | ||
RBC Sel Gr Port Sr T5 | 18.22B | 17.71 | 5.17 | 6.86 | ||
RBC Sel Gr Port Sr A CAD | 18.22B | 17.70 | 5.16 | 6.86 | ||
EdgePoint Glbl Gr Inc Pt non HST F | 10.29B | 12.05 | 7.65 | 8.40 | ||
EdgePoint Global Growth Inc Port A | 10.29B | 10.82 | 6.36 | 7.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Manulife Global Dividend Adv | - | 10.02 | - | - | |
Manulife Bond Adv | - | 8.43 | - | - | |
Manulife US All Cap Equity T6 | - | 7.92 | - | - | |
Manulife Canadian Unconstrained Bond O | - | 7.49 | - | - | |
Manulife IM Emerging Markets Debt | - | 7.46 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review